Patients frequently ask whether Profhilo, skin boosters and dermal fillers achieve the same outcome.
At 101 Harley Street, clarity in treatment planning is fundamental. Each injectable category works in a different anatomical plane and is selected according to whether the objective is structural restoration, hydration improvement or collagen stimulation. Understanding these distinctions allows for more precise and predictable outcomes.
Profhilo is an injectable treatment composed of high-concentration hyaluronic acid. Unlike dermal fillers, it is not designed to add volume or contour. Instead, it disperses beneath the skin to stimulate collagen and elastin production while improving hydration and tissue quality.
It is commonly used to address:
Profhilo® works through bio-remodelling. The product integrates into the tissue and enhances skin behaviour over time rather than altering facial structure.
Skin boosters are injectable treatments formulated to improve hydration, luminosity and superficial skin texture. They contain stabilised hyaluronic acid at lower concentrations than dermal fillers and are placed within more superficial dermal layers.
Their primary purpose is to:
While skin boosters refresh and hydrate, they do not provide structural lift or volume replacement.
Dermal filler treatments are used to restore volume, enhance contour and support facial architecture. They are placed strategically within deeper tissue planes to correct structural volume loss or improve facial proportions.
Dermal fillers may be used to:
In contrast to Profhilo® and skin boosters, dermal fillers physically reshape and support underlying structures.
When comparing Profhilo vs skin boosters vs dermal fillers, it is essential to distinguish between hydration, regeneration and structural augmentation. Although all three treatments involve injectable hyaluronic acid-based products, their behaviour within the tissue and intended outcomes differ significantly. Profhilo is formulated as a stabilised hyaluronic acid complex designed to disperse broadly within the superficial dermis, stimulating collagen and elastin production while improving hydration and skin laxity. Traditional skin boosters are typically placed more superficially and focus primarily on enhancing skin hydration, texture and radiance through micro-depot delivery.
Dermal fillers, by contrast, are engineered to provide structural support and volume restoration. Their rheological properties allow them to lift, contour and reshape areas such as the cheeks, jawline and chin. In a surgical-led environment such as 101 Harley Street, this distinction is critical. Profhilo and skin boosters influence skin quality and behaviour, whereas dermal fillers alter contour and projection. Selecting the appropriate treatment depends on whether the primary concern relates to dermal integrity, early laxity or volume loss secondary to ageing. Careful anatomical assessment ensures that product choice aligns with structural need rather than aesthetic trend.
At 101 Harley Street, injectable treatments are approached through structured consultation and anatomical assessment. The correct treatment depends on whether the concern relates to:
In some cases, combination treatment may be appropriate. Structural restoration with dermal fillers may be complemented by regenerative treatments to improve overlying skin quality.
As a centre focused primarily on surgical procedures, our approach to non-surgical treatments is measured and conservative. Injectable treatments should support facial harmony rather than replace appropriate surgical intervention where structural change is required.
For patients with significant laxity or advanced tissue descent, surgical options may provide more definitive correction. For early changes or skin-quality concerns, non-surgical treatments can play a supportive role.
For patients seeking Profhilo®, skin boosters or dermal fillers within a dedicated non-surgical environment, these treatments are available through L’Atelier Aesthetics, our aesthetic clinic located within 101 Harley Street.
This integrated model allows patients to access both surgical and non-invasive expertise within one setting, ensuring that treatment recommendations remain aligned, appropriate and clinically guided.
